Compound Detail
CHEMBL279516
INDORAMIN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL279516 |
| Name | INDORAMIN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | JXZZEXZZKAWDSP-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
11
Targets
16
Activities
3
Assay Types
13
PK Parameters
20
Publications
7
Known Names
1
Indications
Molecular Properties
347.5
MW (Da)
3.60
ALogP
2
HBA
2
HBD
48.1
PSA (Ų)
0.74
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Hypertension
ATC Classification
C02CA02
indoramin
Level 1: CARDIOVASCULAR SYSTEM
Level 2: ANTIHYPERTENSIVES
Activity Summary
Ki 14 meas. best 8.43
IC50 1 meas.
Kd 1 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 8.7 | 8.7 | 2.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 8.43 | 8.415 | 3.7 | 2 |
| Alpha-1A adrenergic receptor CHEMBL4892 | Ki | 7.92 | 7.92 | 12.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 7.61 | 7.61 | 24.6 | 1 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 7.6 | 7.5133 | 25.0 | 3 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 6.96 | 6.88 | 110.0 | 2 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 6.32 | 6.32 | 476.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 6.28 | 6.28 | 528.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL326 | Ki | 6.21 | 6.21 | 611.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 5.65 | 5.65 | 2240.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 4.92 | 4.92 | 12022.6 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 20.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 46.4 | mL.min-1.g-1 | Homo sapiens |
| F | 49.0 | % | Homo sapiens |
| Fu | 0.15 | - | Homo sapiens |
| MRT | 4.1 | hr | Homo sapiens |
| T1/2 | 4.3 | hr | Homo sapiens |
| T1/2 | 0.2667 | hr | Homo sapiens |
| T1/2 | 0.08333 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7401114 | 10.1021/jm00182a009 | Rattus norvegicus | 13 |
| 6167716 | 10.1021/jm00135a006 | ADMET | 11 |
| 7310808 | 10.1021/jm00143a012 | Canis familiaris | 11 |
| 3806618 | 10.1021/jm00385a022 | Rattus norvegicus | 9 |
| 6312043 | 10.1021/jm00364a013 | Rattus norvegicus | 8 |
| 6133954 | 10.1021/jm00360a013 | Rattus norvegicus | 8 |
| 7310808 | 10.1021/jm00143a012 | Rattus norvegicus | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 16033273 | 10.1021/jm0408969 | Unchecked | 3 |
| 6167716 | 10.1021/jm00135a006 | No relevant target | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 7658428 | 10.1021/jm00018a001 | Alpha-1D adrenergic receptor | 2 |
| 7658428 | 10.1021/jm00018a001 | Alpha-1B adrenergic receptor | 2 |
| 7658428 | 10.1021/jm00018a001 | Alpha-1A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 10891117 | 10.1021/jm0000564 | ADMET | 2 |
| 10891117 | 10.1021/jm0000564 | No relevant target | 2 |
| 9135028 | 10.1021/jm960697s | Adrenergic receptor alpha-1 | 1 |
| 6094812 | 10.1021/jm00378a021 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine